Dr Diana Tait
- Consultant Clinical Oncologist
- Clinical Governance Medical Lead
Dr Tait has been a Consultant at the Royal Marsden since 1988. She has a specialist interest in upper gastrointestinal (GI), colorectal and breast cancers and a particular interest in GI chemoradiotherapy and the use of modern radiotherapy technologies for optimising treatment including CyberKnife and cone beam radiotherapy.
Dr Tait is Clinical Governance Medical Lead, and during her career has established a number of committees to audit procedures and improve communication between departments, patients and other centres.
She has chaired the Clinical Audit Committee at the Royal College of Radiologists (RCR) and has been responsible for audit nationally since 2005. Since January 2009 Dr Tait has been Clinical Lead for the Colorectal Guidelines Development Group for NICE (National Institute for Clinical Excellence), with new guidance due to be available in April 2011. In addition, Dr Tait has recently been appointed as Registrar in the Faculty of Clinical Oncology at the RCR.
Dr Tait is actively involved in research. She is principal investigator on a number of studies with the focus around using new radiotherapy technologies to improve patients’ treatment management.
Dr Tait is currently principal investigator on one rectal study which is investigating the optimum time to surgery following pre-op chemoradiotherapy. A second study involves intensive follow-up for patients who want to avoid rectal surgery altogether by adopting a ‘watch and wait’ policy.
Dr Tait is Clinical Oncology Lead on national and international GI research and collaborates on associated studies in both GI and breast cancer.